The purpose of this study is to examine patient experiences, health-related quality of life, and decision-making associated with PET imaging for prostate cancer. In particular, Prostate Specific Membrane Antigen (PSMA) PET, a new and more sensitive form of imaging that can help identify metastatic cancer earlier and more reliably.
Prostate Cancer
The purpose of this study is to examine patient experiences, health-related quality of life, and decision-making associated with PET imaging for prostate cancer. In particular, Prostate Specific Membrane Antigen (PSMA) PET, a new and more sensitive form of imaging that can help identify metastatic cancer earlier and more reliably.
PRISM: Patient Experiences With PET Imaging in Prostate Cancer
-
Yale New Haven Health Bridgeport Hospital - Park Ave Medical Center, Bridgeport, Connecticut, United States, 06611
Griffin Hospital, Derby, Connecticut, United States, 06418
Yale New Haven Health Greenwich Hospital, Greenwich, Connecticut, United States, 06830
Radiology and Biomedical Imaging - New Haven - Smilow Cancer Hospital (North Pavilion):, New Haven, Connecticut, United States, 06520
Saint Raphael's Radiology and Biomedical Imaging, Basement Location., New Haven, Connecticut, United States, 06520
Yale New Haven Health Lawrence & Memorial Hospital, New London, Connecticut, United States, 06320
Yale New Haven Health Westerly Hospital, Westerly, Rhode Island, United States, 02891
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Yale University,
Michael Leapman, MD, PRINCIPAL_INVESTIGATOR, Yale School of Medicine
2028-07